Company Overview
Snapshot
Founded in January 2021 by Dor Oppenheim and Lyor Rabinowiz, ReGen operates with 1–10 employees. The company has completed 3 funding rounds, including a grant received in March 2024. ReGen is currently in the pilot stage, conducting field trials in Israel for its microbiome-coated seeds, with plans for commercial launch next year.
Business overview
ReGen develops advanced biological and AI-powered solutions for regenerative agriculture. The company's core technology includes microbial-based products, such as seed coatings and soil amendments, designed to enhance plant nutrition, boost yields, and restore soil health. ReGen also utilizes a proprietary AI system to provide real-time insights into crop nutritional status, facilitating adaptive agronomic strategies that reduce reliance on agrochemicals. By integrating natural, non-GMO microbial inputs with data-driven regenerative practices, ReGen aims to increase agricultural productivity and promote long-term sustainability for farmers and food companies, operating within the Agriculture & Food Technologies sector.
Strategic signal
In February 2025, ReGen announced that its microbiome technology, which aims to restore soil health and improve crop performance through seed coatings, is in the pilot stage with field trials underway in Israel. This signals the company's progress toward commercialization and its commitment to providing sustainable agricultural solutions. The development is crucial for investors as it demonstrates tangible advancement in addressing soil degradation and reducing dependency on synthetic chemicals, positioning ReGen as a key player in the evolving regenerative agriculture market.
Log in to access full profile ›Company Intelligence Q&A
- When was ReGen founded and by whom?
- ReGen was founded in January 2021 by Dor Oppenheim and Lyor Rabinowiz.
- What is ReGen's primary focus in agriculture?
- ReGen focuses on developing advanced biological and AI-powered solutions for regenerative agriculture, utilizing microbial-based products and data-driven insights to improve soil health and crop performance.
- What is the current status of ReGen's product development?
- As of February 2025, ReGen's microbiome technology, including its seed coatings, is in the pilot stage with field trials actively underway in Israel. The company plans for a commercial launch next year.
- Has ReGen received any grants or significant support?
- In March 2024, ReGen received a grant from the Israel Innovation Authority, indicating external validation and support for its technology.
- What problem does ReGen's technology address?
- ReGen's technology addresses soil degradation caused by synthetic chemicals by developing seed coatings with tailored microbiomes to enhance plant growth and reduce the need for synthetic fertilizers and pesticides, promoting sustainable agricultural practices.